We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.95T
$144M 2.49%
1,679,486
+50,696
+3% +$4.16M
AAPL icon
2
Apple
AAPL
$4.81T
$122M 2.11%
2,884,680
+177,488
+7% +$7.42M
AMGN icon
3
Amgen
AMGN
$198B
$109M 1.88%
624,747
+161,172
+35% +$28.5M
META icon
4
Meta Platforms (Facebook)
META
$1.63T
$94.5M 1.64%
535,558
+146,947
+38% +$26M
BABA icon
5
Alibaba
BABA
$283B
$91.6M 1.58%
531,048
+73,599
+16% +$13.2M
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.24T
$81.6M 1.41%
1,549,220
+287,760
+23% +$14.9M
CELG
7
DELISTED
Celgene Corp
CELG
$79.1M 1.37%
757,531
-52,157
-6% -$5.89M
XOM icon
8
ExxonMobil
XOM
$629B
$76.3M 1.32%
911,777
-95,513
-9% -$7.9M
JPM icon
9
JPMorgan Chase
JPM
$918B
$69.9M 1.21%
653,598
+154,262
+31% +$15.6M
AMZN icon
10
Amazon
AMZN
$2.66T
$67.5M 1.17%
1,154,740
-366,500
-24% -$20.2M
PG icon
11
Procter & Gamble
PG
$345B
$60.7M 1.05%
660,497
+97,496
+17% +$8.77M
GILD icon
12
Gilead Sciences
GILD
$162B
$56.4M 0.98%
787,405
-348,796
-31% -$26.5M
VRTX icon
13
Vertex Pharmaceuticals
VRTX
$122B
$53.3M 0.92%
355,775
-3,087
-0.9% -$457K
CL icon
14
Colgate-Palmolive
CL
$72.4B
$48.9M 0.85%
648,526
+136,541
+27% +$9.97M
JNJ icon
15
Johnson & Johnson
JNJ
$603B
$46.8M 0.81%
334,877
-199,812
-37% -$27.8M
REGN icon
16
Regeneron Pharmaceuticals
REGN
$70.8B
$45.5M 0.79%
121,092
-9,900
-8% -$4.01M
V icon
17
Visa
V
$677B
$45M 0.78%
394,521
+59,978
+18% +$6.62M
T icon
18
AT&T
T
$155B
$44.5M 0.77%
1,514,485
-24,171
-2% -$660K
BIDU icon
19
Baidu
BIDU
$36.8B
$44.2M 0.76%
188,510
+38,990
+26% +$9.53M
DIS icon
20
Walt Disney
DIS
$167B
$43.4M 0.75%
403,364
+82,285
+26% +$8.48M
LUV icon
21
Southwest Airlines
LUV
$23.8B
$43.2M 0.75%
660,391
+282,911
+75% +$16.6M
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.06T
$42.2M 0.73%
213,101
+33,828
+19% +$6.42M
C icon
23
Citigroup
C
$223B
$42.1M 0.73%
566,324
+31,045
+6% +$2.3M
LLY icon
24
Eli Lilly
LLY
$1.05T
$41.1M 0.71%
486,492
+56,068
+13% +$4.77M
VZ icon
25
Verizon
VZ
$183B
$41M 0.71%
775,083
-30,331
-4% -$1.49M

Similar funds

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.